The Cosmetic Surgery Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Cosmetic Surgery Global Market has been experiencing robust growth in recent years. The market size surged from $53.34 billion in 2024 and is projected to reach $58.62 billion in 2025, increasing at a compound annual growth rate (CAGR) of 9.9%.
In 2029, the global cosmetic surgery market is projected to reach a size of $79.41 billion, with a compound annual growth rate (CAGR) of 7.9%.
Download Your Free Sample of the 2025 Cosmetic Surgery Market Report and Uncover Key Trends Now!The key drivers in the cosmetic surgery market are:
• Rise in non-invasive procedures
• Cultural acceptance of cosmetic surgery
• Growth of the aging population worldwide
• Increased accessibility of information about cosmetic procedures.
The cosmetic surgery market covered in this report is segmented –
1) By Procedure Type: Surgical Procedures, Non-Surgical Procedures, Other Procedures
2) By Provider: Spas And Cosmetic Surgery Centers, Hospitals And Specialty Clinics
3) By Gender: Male, Female
4) By Application: Liposuction, Eyelid And Nose Surgery, Body Contouring, Face Reconstruction, Cosmetic Implants, Other Applications
5) By End-User: Hospitals, Surgical Centers, Other End-Users
The key trends in the cosmetic surgery market are:
• The integration of technology into cosmetic surgery procedures is an emerging trend.
• There's a visible shift towards non-invasive and minimally invasive techniques in cosmetic surgeries.
• Personalized and customizable procedures are becoming increasingly popular in the market.
• Integration of regenerative medicine in cosmetic surgeries, facilitated by technologies like 3D imaging and simulation, is shaping the future of the market.
Major companies in the cosmetic surgery market are:
• Johnson & Johnson
• Astellas Pharma Inc.
• Novartis AG
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Medtronic plc
• Polytech Health & Aesthetics GmbH
• AbbVie Inc.
• Daiichi Sankyo Co. Ltd.
• Mylan N.V.
• Bausch Health Companies Inc.
• Eisai R&D Inc.
• Kyowa Hakko Kirin Co. Ltd.
• Ferring Pharmaceuticals plc
• Endo Pharmaceuticals plc
• Galderma SA
• Lumenis Ltd.
• Solta Medical Inc.
• Evolus Inc.
• Revance Therapeutics Inc.
• Syneron Candela Corporation
• Alma Lasers Ltd.
• Sinclair Pharma plc
• HansBiomed Co. Ltd.
• Teoxane Laboratories
• Cynosure Inc.
• Merz Pharma GmbH & Co. KGaA
• Vital Esthetique Inc.
• GC Aesthetics LLC
• Ono Pharmaceutical Co. Ltd.
• Otsuka Pharmaceutical Co. Ltd.
• Shionogi & Co. Ltd.
North America was the largest region in the cosmetic surgery market in 2024 and is expected to be the fastest-growing region in the forecast period